ALL CITATIONS

• Propranolol therapy for Tardive dyskinesia: A retrospective examination, Parkinsonism & Related Disorders
  DOI: http://doi.org/10.1016/j.parkreldis.2016.09.004
  
  
• Randomized controlled trial of deutetrabenazine for tardive dyskinesia, Neurology 88(21),
  DOI: http://doi.org/10.1212/WNL.0000000000003960
  
  
• Tremor analysis separates Parkinson’s disease and dopamine receptor blockers induced parkinsonism, Neurological Sciences 38(5),
  DOI: http://doi.org/10.1007/s10072-017-2852-6
  
  
• Valbenazine for the treatment of tardive dyskinesia, Expert Opinion on Pharmacotherapy 18(12),
  DOI: http://doi.org/10.1080/14656566.2017.1353078
  
  
• Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial, The Lancet Psychiatry 4(8),
  DOI: http://doi.org/10.1016/S2215-0366(17)30236-5
  
  
• Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials, Drug Safety 41(4),
  DOI: http://doi.org/10.1007/s40264-017-0623-1
  
  
• Tardive dyskinesia risk with first‐ and second‐generation antipsychotics in comparative randomized controlled trials: a meta‐analysis, World Psychiatry 17(3),
  DOI: http://doi.org/10.1002/wps.20579
  
  
• Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors, Drugs 78(5),
  DOI: http://doi.org/10.1007/s40265-018-0874-x
  
  
• VMAT2 inhibitors for the treatment of tardive dyskinesia, Journal of the Neurological Sciences
  DOI: http://doi.org/10.1016/j.jns.2018.02.006
  
  
• Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia, BMC Psychiatry 18(1),
  DOI: http://doi.org/10.1186/s12888-018-1889-2
  
  
• Tardive dyskinesia update: the syndrome, BJPsych Advances 25(1),
  DOI: http://doi.org/10.1192/bja.2018.45
  
  
• Recent developments in drug-induced movement disorders: a mixed picture, The Lancet Neurology 18(9),
  DOI: http://doi.org/10.1016/S1474-4422(19)30152-8
  
  
• Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia, Journal of Managed Care & Specialty Pharmacy 25(7),
  DOI: http://doi.org/10.18553/jmcp.2019.25.7.810
  
  
• The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders, Current Medical Research and Opinion 35(7),
  DOI: http://doi.org/10.1080/03007995.2019.1569871
  
  
• Lurasidone‐Induced Tardive Syndrome, Movement Disorders Clinical Practice 6(7),
  DOI: http://doi.org/10.1002/mdc3.12812
  
  
• Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States, PLOS ONE 14(6),
  DOI: http://doi.org/10.1371/journal.pone.0216044
  
  
• A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia, Journal of Clinical Psychopharmacology 39(6),
  DOI: http://doi.org/10.1097/JCP.0000000000001111
  
  
• Deutetrabenazine in the treatment of tardive dyskinesia, Neurodegenerative Disease Management 9(2),
  DOI: http://doi.org/10.2217/nmt-2018-0042
  
  
• Treatment Recommendations for Tardive Dyskinesia, The Canadian Journal of Psychiatry 64(6),
  DOI: http://doi.org/10.1177/0706743719828968
  
  
• Implications of Antipsychotic Use, Nursing Clinics of North America 54(4),
  DOI: http://doi.org/10.1016/j.cnur.2019.08.004
  
  
• Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington’s disease: a review of clinical trial data, Expert Opinion on Pharmacotherapy 20(18),
  DOI: http://doi.org/10.1080/14656566.2019.1674281
  
  
• Management of Tardive Syndrome: Medications and Surgical Treatments, Neurotherapeutics
  DOI: http://doi.org/10.1007/s13311-020-00898-3
  
  
• Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia, BMC Psychiatry 20(1),
  DOI: http://doi.org/10.1186/s12888-020-02748-0
  
  
• A long-term, open-label study of valbenazine for tardive dyskinesia, CNS Spectrums
  DOI: http://doi.org/10.1017/S109285292000108X
  
  
• Treatment of Tardive Dyskinesia, Neurologic Clinics 38(2),
  DOI: http://doi.org/10.1016/j.ncl.2020.01.004
  
  
• Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders, Journal of Medical Economics 23(2),
  DOI: http://doi.org/10.1080/13696998.2019.1685818
  
  
• Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice, CNS Spectrums
  DOI: http://doi.org/10.1017/S109285292000200X
  
  
• Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement, Surgical Neurology International
  DOI: http://doi.org/10.25259/SNI_723_2020
  
  
• Recognition and Treatment of Tardive Dyskinesia in Individuals with Intellectual Disability, Case Reports in Psychiatry
  DOI: http://doi.org/10.1155/2020/8886980
  
  
• Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia, Expert Review of Neurotherapeutics
  DOI: http://doi.org/10.1080/14737175.2021.1848548
  
  
• Recent Advances in the Pharmacology of Tardive Dyskinesia, Clinical Psychopharmacology and Neuroscience 18(4),
  DOI: http://doi.org/10.9758/cpn.2020.18.4.493
  
  
• Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia, Journal of Medical Economics
  DOI: http://doi.org/10.1080/13696998.2020.1867443
  
  
• Tardive Dyskinesia: Spotlight on Current Approaches to Treatment, FOCUS 19(1),
  DOI: http://doi.org/10.1176/appi.focus.20200038
  
  
• A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse, Schizophrenia Bulletin
  DOI: http://doi.org/10.1093/schbul/sbab017
  
  
• Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project, The World Journal of Biological Psychiatry
  DOI: http://doi.org/10.1080/15622975.2021.1938213
  
  
• A Comprehensive Review of Tic Disorders in Children, Journal of Clinical Medicine 10(11),
  DOI: http://doi.org/10.3390/jcm10112479
  
  
• VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia, Issues in Mental Health Nursing
  DOI: http://doi.org/10.1080/01612840.2021.1948643
  
  
• Treatable Hyperkinetic Movement Disorders Not to Be Missed, Frontiers in Neurology
  DOI: http://doi.org/10.3389/fneur.2021.659805
  
  
• Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5–14 years, Journal of Neurology
  DOI: http://doi.org/10.1007/s00415-022-10965-8